Viewing Study NCT04352595


Ignite Creation Date: 2025-12-24 @ 1:18 PM
Ignite Modification Date: 2026-03-05 @ 3:30 AM
Study NCT ID: NCT04352595
Status: COMPLETED
Last Update Posted: 2024-03-01
First Post: 2020-03-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module